Parnax Lab Ltd (PARNAXLAB) Financials - Quarterly Results, Profit & Loss, Balance Sheet, Cash Flow Parnax Lab Ltd reported sales of ₹56.8 Cr, operating profit of ₹4.31 Cr (OPM 7.59%) and net profit of ₹0.43 Cr for the quarter ended Jun 2026. Figures in ₹ crore, consolidated where available.
PARNAXLAB quarterly results (₹ Cr) Metric Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026 Sales 48.36 40.22 49.04 53.38 62.6 62.94 69.63 56.8 Expenses 41.12 35.95 42.41 45.94 54.52 56.09 64.75 52.49 Operating Profit 7.24 4.27 6.63 7.44 8.08 6.85 4.88 4.31 OPM 14.97% 10.62% 13.52% 13.94% 12.91% 10.88% 7.01% 7.59% Other Income 0.95 0.19 0.43 0.18 0.63 -0.17 1.76 0.15 Interest 1.38 1.23 1.28 1.22 1.4 1.47 1.61 1.64 Depreciation 1.94 1.79 1.83 1.94 2.1 1.96 2.04 2.22 Profit before tax 4.87 1.44 3.95 4.46 5.21 3.25 2.99 0.6 Tax 29.77% 16.67% 26.08% 26.46% 30.33% 16.62% 27.09% 28.33% Net Profit 3.42 1.21 2.93 3.28 3.62 2.71 2.19 0.43 EPS in Rs 2.97 1.05 2.54 2.85 3.16 2.36 1.9 0.37
PARNAXLAB profit & loss, annual (₹ Cr) Metric Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 TTM Sales 163 168 189 188 249 252 Expenses 140 145 165 161 221 228 Operating Profit 23 23 24 27 27 24 OPM 14% 14% 12% 14% 11% 10% Other Income 0 1 1 1 2 2 Interest 5 5 5 5 6 6 Depreciation 6 7 7 7 8 8 Profit before tax 12 12 12 16 16 12 Tax 33% 30% 20% 26% 26% - Net Profit 8 9 10 12 12 9 EPS in Rs 8.4 7.51 8.37 10.03 10.26 7.79 Dividend Payout 0% 0% 0% 0% 0% -
PARNAXLAB balance sheet (₹ Cr) Metric Mar 2023 Mar 2024 Mar 2025 Sep 2025 Mar 2026 Equity Capital 11 11 11 11 11 Reserves 51 60 72 78 84 Borrowings 55 81 70 69 83 Other Liabilities 28 38 37 50 50 Total Liabilities 145 190 190 208 228 Fixed Assets 77 89 88 113 115 CWIP 2 21 29 14 11 Investments 0 0 0 0 0 Other Assets 66 80 72 82 101 Total Assets 145 190 190 208 228
PARNAXLAB cash flows (₹ Cr) Metric Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 Cash from Operating Activity 9 21 16 32 8 Cash from Investing Activity -16 -10 -32 -16 -16 Cash from Financing Activity 12 -14 15 -16 8 Net Cash Flow 4 -3 -1 0 0 Free Cash Flow -8 11 -16 16 -9 CFO/OP 38% 103% 79% 130% 42%
PARNAXLAB ratios Metric Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 Debtor Days 85 61 63 60 56 Inventory Days 73 79 94 87 90 Days Payable 81 53 74 72 80 Cash Conversion Cycle 77 86 83 75 65 Working Capital Days -35 -19 -23 -24 -11 ROCE 17% 15% 13% 14% 14%